Page last updated: 2024-11-04

succinylacetone and Liver Cirrhosis

succinylacetone has been researched along with Liver Cirrhosis in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackburn, PR1
Hickey, RD1
Nace, RA1
Giama, NH1
Kraft, DL1
Bordner, AJ1
Chaiteerakij, R1
McCormick, JB1
Radulovic, M1
Graham, RP1
Torbenson, MS1
Tortorelli, S1
Scott, CR1
Lindor, NM1
Milliner, DS1
Oglesbee, D1
Al-Qabandi, W1
Grompe, M1
Gavrilov, DK1
El-Youssef, M1
Clark, KJ1
Atwal, PS1
Roberts, LR1
Klee, EW1
Ekker, SC1

Other Studies

1 other study available for succinylacetone and Liver Cirrhosis

ArticleYear
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.
    Human mutation, 2016, Volume: 37, Issue:10

    Topics: Adolescent; Animals; Carcinoma, Hepatocellular; Catalytic Domain; Cell Line, Tumor; Child; Child, Pr

2016